Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1999Expert Opinion on Therapeutic Patents

Neurokinin receptor antagonists

View Full Paper
Ask AI
Bookmark
Share

Authors

ESEileen M. SewardCharles River Laboratories (United Kingdom)CSChristopher J. SwainUniversity of Cambridge

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Seward et al. (1999) studied this question.

synapsesocial.com/papers/6a9b37f17a97dde76dee1d2dhttps://doi.org/10.1517/13543776.9.5.571
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Effect of Inhaled FK224, a Tachykinin NK-1 and NK-2 Receptor Antagonist, on Neurokinin A-Induced Bronchoconstriction in Asthmatics1996 · 87 citations
  2. 2Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine1997 · 223 citations
  3. 3The non‐peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats1993 · 104 citations
  4. 4Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors1998 · 1,079 citations